|
|
Thormøhlensgate 55
Bergen, NOR N-5008 Norway
phone:+47 55 54 39 60
fax:(47) (0) 55 54 38 98
|
|
| Symbol |
NORD |
| Exchange |
OSL |
| Founded |
0 |
| Employees |
|
|
|
| www.nordiag.no
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Early diagnosis/screening of colorectal cancer. |
|
| Management |
| Christian Horn (1967), Chief Executive Officer; Guido Guidetti (1950), Vice President Sales and Marketing; Dr. David Parker (1953), Chief Scientific Officer; Dr. Roger Lvlie (1971), Vice President Laboratory Operations; Marit Austgulen Wick (1967), Chief Financial Officer; Dr. Jochen Felbel (1962), MBA, Medical Director; Prof. Dr. Med Dagfinn greid (1956), Clinical Director |
| |
|
|
|
|
|
|
|
| Keywords |
| biotechnological, diagnosis, colorectal, cancer, genetics, molecular, biology, genefec |
|
|
|
| Description |
|
NorDiag is involved in early diagnosis/screening of colorectal cancer, research and development activities within colorectal cancer genetics and molecular biology. |
|
| Products / Services |
NorDiag's product GENEFEC test is an early and accurate indicator of Colorectal Cancer. GENEFEC test targets specifically for the Ki-ras oncogene which is mutated in the transition from early to intermediate stage, up to 5 years before actual cancer is developed.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members